Published guidance, NICE advice and quality standards | Guidance

Showing 311 to 320 of 797

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Enzalutamide for treating hormone-sensitive metastatic prostate cancer	TA712	7 July 2021	7 July 2021
Nivolumab for advanced non-squamous non-small-cell lung cancer after chemotherapy	TA713	7 July 2021	7 July 2021
Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation	TA249	15 March 2012	2 July 2021
Rivaroxaban for the prevention of stroke and systemic embolism in people with atrial fibrillation	TA256	23 May 2012	2 July 2021
Edoxaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation	TA355	23 September 2015	2 July 2021
Apixaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation	TA275	27 February 2013	2 July 2021
Budesonide orodispersible tablet for inducing remission of eosinophilic oesophagitis	TA708	23 June 2021	23 June 2021
Pembrolizumab for untreated metastatic colorectal cancer with high microsatellite instability or mismatch repair deficiency	TA709	23 June 2021	23 June 2021
Ravulizumab for treating atypical haemolytic uraemic syndrome	TA710	23 June 2021	23 June 2021
Nivolumab for previously treated unresectable advanced or recurrent oesophageal cancer	TA707	15 June 2021	15 June 2021